S. Henriot

Human CRF2 α and β splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay

Ali Ardati, Valérie Goetschy, Juergen Gottowick et al. · Neuropharmacology · 1999 · 50 citations

Medicine, Pharmacology, Molecular Pharmacology +4

Labelling of CRF1 and CRF2 receptors using the novel radioligand, [3H]-urocortin

Juergen Gottowik, Valérie Goetschy, S. Henriot et al. · Neuropharmacology · 1997 · 43 citations

Medicine, Biochemistry, Pharmacology +4

Lazabemide (Ro 19-6327), a reversible and highly sensitive MAO-B inhibitor: preclinical and clinical findings

S. Henriot, C Kuhn, R. Kettler et al. · 1994 · 23 citations

Medicine, Medicinal Chemistry, Pharmacology +11

Pharmacological characterisation of the recombinant human CRF binding protein using a simple assay

Ali Ardati, Juergen Gottowik, S. Henriot et al. · Journal of Neuroscience Methods · 1998 · 11 citations

Medicine, Biochemistry, Pharmacology +11

Urocortin: slower dissociation than corticotropin releasing factor from the CRF binding protein

S. Henriot, Frank M. Dautzenberg, Gavin J. Kilpatrick · European Journal of Pharmacology · 1999 · 10 citations

Life Sciences, Endocrinology, Physiology +3